Northwest Biotherapeutics, Inc. Share Price
Stocks
NWBO
US66737P6007
Biotechnology & Medical Research
OTC Markets Traded|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 0.2050 USD | +0.49% |
|
+19.26% | -10.40% |
| Market Cap | 288M 252M 235M 215M 406M 27.8B 412M 2.79B 1.09B 13.59B 1.08B 1.06B 46.96B | P/E 2026 * |
-
| P/E 2027 * | - |
|---|---|---|---|---|---|
| Enterprise Value | 384M 337M 313M 287M 541M 37.08B 550M 3.72B 1.46B 18.13B 1.44B 1.41B 62.63B | EV / Sales 2026 * |
-
| EV / Sales 2027 * | 10.6x |
| Free-Float |
95.04% | Yield 2026 * |
-
| Yield 2027 * | - |
| 1 day | +0.49% | ||
| 1 week | +19.26% | ||
| Current month | +9.74% | ||
| 1 month | +5.45% | ||
| 3 months | +5.40% | ||
| 6 months | -29.36% | ||
| Current year | -10.40% |
| 1 week | 0.14 |  | 0.21 |
| 1 month | 0.14 | | 0.24 |
| Current year | 0.14 | | 0.34 |
| 1 year | 0.14 | | 0.37 |
| 3 years | 0.14 | | 1.09 |
| 5 years | 0.14 | | 2.05 |
| 10 years | 0.14 | | 2.51 |
| Manager | Title | Age | Since |
|---|---|---|---|
Linda Powers
CEO | Chief Executive Officer | 71 | 07/06/2011 |
Alton Boynton
CEO | Chief Executive Officer | 82 | 31/05/2007 |
Marnix Bosch
CTO | Chief Tech/Sci/R&D Officer | 67 | 31/12/1999 |
| Director | Title | Age | Since |
|---|---|---|---|
Alton Boynton
BRD | Director/Board Member | 82 | 31/12/1997 |
Linda Powers
CHM | Chairman | 71 | 16/05/2007 |
Navid Malik
BRD | Director/Board Member | 57 | 31/03/2012 |
| Date | Insider | Type | Main position | Quantity | % Market Cap. | |
|---|---|---|---|---|---|---|
| 29/08/24 | Don | Founder | 1,000,000 | 0.0826% | ||
| 09/08/24 | Don | Chief Technology Officer | 3,000,000 | 0.2478% | ||
| 08/08/24 | Don | Founder | 1,000,000 | 0.0826% |
| Change | 5-day change | 1-year change | 3-year change | Capi.($) | ||
|---|---|---|---|---|---|---|
 | +0.49% | +19.26% | -18.00% | -62.04% | 288M | |
| -0.43% | -1.26% | +52.13% | +85.69% | 55.57B | |
| -0.24% | -0.37% | +57.02% | +54.21% | 54.26B | |
| -0.54% | +1.58% | -15.68% | -15.43% | 23.35B | |
| -1.82% | -3.15% | +3.76% | +405.88% | 23.54B | |
| +0.05% | +1.68% | +38.71% | -4.57% | 20.32B | |
| +3.16% | +2.74% | +37.33% | -31.36% | 17.36B | |
| +1.08% | +3.77% | +36.92% | +593.96% | 15.59B | |
| +0.43% | -1.67% | +166.53% | +299.61% | 14.96B | |
| -2.03% | -1.42% | +24.22% | +179.23% | 14.11B | |
| Average | +0.02% | -0.20% | +38.29% | +150.52% | 23.93B | |
| Weighted average by Cap. | -0.17% | -0.23% | +44.08% | +135.85% |
| 2026 * | 2027 * | |
|---|---|---|
| Net sales | - | 38.93M 34.13M 31.71M 29.12M 54.85M 3.76B 55.71M 378M 148M 1.84B 146M 143M 6.35B |
| Net income | - | - |
| Net Debt | 96.08M 84.22M 78.25M 71.86M 135M 9.28B 137M 932M 364M 4.54B 361M 353M 15.67B | 125M 110M 102M 93.44M 176M 12.06B 179M 1.21B 474M 5.9B 469M 459M 20.38B |
Employees
105
| Date | Price | Change | Volume |
|---|---|---|---|
| 22/07/26 | US$0.1738 | +1.87% | 3,010,242 |
| 21/07/26 | US$0.1706 | -3.62% | 2,683,190 |
| 20/07/26 | US$0.1770 | +4.91% | 3,260,195 |
| 17/07/26 | US$0.1687 | +9.92% | 6,457,470 |
| 16/07/26 | US$0.1535 | -7.25% | 11,162,504 |
Sell
Buy
Mean consensus
OUTPERFORM
Number of Analysts
1
Last Close Price
0.1738USD
Average target price
1.000USD
Spread / Average Target
+475.46%
Annual profits - Rate of surprise
- Stock Market
- Stocks
- NWBO Stock
Select your edition
All financial news and data tailored to specific country editions
